Literature DB >> 7558341

Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla.

L O Bakaletz1, D M Murwin, J M Billy.   

Abstract

A chinchilla model of otitis media in which adenovirus compromise of the tubotympanum facilitates the subsequent induction of middle ear disease was used to investigate Moraxella (Branhamella) catarrhalis pathogenesis. Intranasally inoculated M. catarrhalis did readily colonize the nasopharynx of this host; however, despite evidence of viral infection and tubotympanal compromise, M. catarrhalis did not induce culture-positive otitis media in this model.

Entities:  

Mesh:

Year:  1995        PMID: 7558341      PMCID: PMC173592          DOI: 10.1128/iai.63.10.4188-4190.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Branhamella catarrhalis--an emerging human pathogen.

Authors:  G V Doern
Journal:  Diagn Microbiol Infect Dis       Date:  1986-03       Impact factor: 2.803

Review 2.  Viral potentiation of bacterial superinfection of the respiratory tract.

Authors:  L O Bakaletz
Journal:  Trends Microbiol       Date:  1995-03       Impact factor: 17.079

3.  Nasopharyngeal carriage of bacteria in otitis-prone and non-otitis-prone children in day-care centres.

Authors:  K Prellner; P Christensen; B Hovelius; C Rosén
Journal:  Acta Otolaryngol       Date:  1984 Sep-Oct       Impact factor: 1.494

4.  Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis.

Authors:  L C Bartos; T F Murphy
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

5.  Experimental otitis media with effusion following middle ear inoculation of nonviable H influenzae.

Authors:  T F DeMaria; B R Briggs; D J Lim; N Okazaki
Journal:  Ann Otol Rhinol Laryngol       Date:  1984 Jan-Feb       Impact factor: 1.547

6.  Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas.

Authors:  G S Giebink; I K Berzins; S C Marker; G Schiffman
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

7.  Acute otitis media caused by Branhamella catarrhalis: biology and therapy.

Authors:  G F Van Hare; P A Shurin; C D Marchant; N A Cartelli; C E Johnson; D Fulton; S Carlin; C H Kim
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

8.  Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease.

Authors:  J A Pollard; R J Wallace; D R Nash; J I Luman; R W Wilson
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 9.  Branhamella catarrhalis respiratory infections.

Authors:  H Hager; A Verghese; S Alvarez; S L Berk
Journal:  Rev Infect Dis       Date:  1987 Nov-Dec

10.  Correlation between Branhamella catarrhalis adherence to oropharyngeal cells and seasonal incidence of lower respiratory tract infections.

Authors:  N Mbaki; N Rikitomi; T Nagatake; K Matsumoto
Journal:  Tohoku J Exp Med       Date:  1987-10       Impact factor: 1.848

View more
  19 in total

1.  A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media.

Authors:  Glen McGillivary; William C Ray; Charles L Bevins; Robert S Munson; Lauren O Bakaletz
Journal:  Mol Immunol       Date:  2006-11-20       Impact factor: 4.407

2.  Evidence for transudation of specific antibody into the middle ears of parenterally immunized chinchillas after an upper respiratory tract infection with adenovirus.

Authors:  L O Bakaletz; K A Holmes
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

3.  Replication of type 5 adenovirus promotes middle ear infection by Streptococcus pneumoniae in the chinchilla model of otitis media.

Authors:  Kyle A Murrah; Roberta L Turner; Bing Pang; Antonia C Perez; Jennifer L Reimche; Lauren B King; John Wren; Uma Gandhi; W Edward Swords; David A Ornelles
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

4.  Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalis.

Authors:  Todd C Hoopman; Wei Liu; Stephanie N Joslin; Christine Pybus; Jennifer L Sedillo; Maria Labandeira-Rey; Cassie A Laurence; Wei Wang; James A Richardson; Lauren O Bakaletz; Eric J Hansen
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

5.  Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection.

Authors:  L O Bakaletz; B J Kennedy; L A Novotny; G Duquesne; J Cohen; Y Lobet
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Bacterium-generated nitric oxide hijacks host tumor necrosis factor alpha signaling and modulates the host cell cycle in vitro.

Authors:  Brian Mocca; Wei Wang
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

7.  Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus.

Authors:  Negin Gitiban; Joseph A Jurcisek; Randall H Harris; Sara E Mertz; Russell K Durbin; Lauren O Bakaletz; Joan E Durbin
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.

Authors:  Elizabeth A Ruckdeschel; Aimee L Brauer; Antoinette Johnson; Timothy F Murphy
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

9.  Development of a LacZ-based transcriptional reporter system for use with Moraxella catarrhalis.

Authors:  Amanda S Evans; Christine Pybus; Eric J Hansen
Journal:  Plasmid       Date:  2012-12-04       Impact factor: 3.466

Review 10.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.